News

G204 is a double-blind, placebo-controlled cumulative dose selection study for grass allergic rhinitis, which follows the successful completion of the GMM102 (G102) safety study, which demonstrated safety of

The OPTIC-2L (Optimizing Ponatinib Treatment In CML, Second Line) trial is designed to investigate the efficacy and safety of ponatinib, administered at two starting doses, compared with nilotinib,

KTE-C19 is an investigational therapy in which a patient’s T cells are genetically modified to express a chimeric antigen receptor designed to target the antigen CD19, a protein

Both products are formulated with aloe vera and Cortivera™ contains 0.5% hydrocortisone and Cortivera Plus™ contains 1% hydrocortisone. Both are available in cream and ointment form in order

The financing, which was supported by institutional investors in the US and Europe, will support the continued clinical development of the company’s ERY-ASP/GRASPA. ERY-ASP/GRASPA is designed specifically to

Evofosfamide, earlier known as TH-302, failed to improve overall survival when combined with chemotherapy in the two indications. Evofosfamide is an investigational hypoxia-activated prodrug of a bis-alkylating agent

The program is part of a collaboration between AstraZeneca and its worldwide biologics research and development unit MedImmune. It is intended at developing and commercializing durvalumab across various

Bial director of research & development department Patrício Soares-da-Silva said: "The study met its primary endpoint, which was the proportion of seizure-free patients for six consecutive months under

In the study, adult patients under 60 years of age with newly-diagnosed FLT3-mutated acute myeloid leukemia (AML) who received the investigational compound PKC412 (midostaurin) plus standard induction and